W.R. Berkley Corp’s Organogenesis Holdings ORGO Stock Holding History

W.R. Berkley Corp’s Portfolio ORGO Stock Details ORGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-1,108,178	Closed	-$11.2M	–	92
2018 Q3	$11.2M	Buy	1,108,178 +208,181	+23%	+$2.1M	1.73%	19
2018 Q2	$9.03M	Buy	899,997 +248,265	+38%	+$2.49M	1.25%	24
2018 Q1	$6.46M	Hold	651,732	–	–	0.88%	29
2017 Q4	$6.46M	Hold	651,732	–	–	0.69%	30
2017 Q3	$6.52M	Sell	651,732 -24,138	-4%	-$240K	0.87%	18
2017 Q2	$6.66M	Buy	675,870 +96,900	+17%	+$953K	0.71%	22
2017 Q1	$5.7M	Buy	+578,970	New	+$5.72M	0.86%	19

W.R. Berkley Corp's ORGO Position: Q4 2018 in Review

W.R. Berkley Corp sold out of Organogenesis Holdings (ORGO) in Q4 2018, closing a stake of 1,108,178 shares — an estimated $11.2M sold.

W.R. Berkley Corp first reported a position in ORGO in Q1 2017 and held it in 7 quarters. The position peaked at $11.2M in Q3 2018. 0 funds tracked by Wall St. Rank hold ORGO as of Q4 2018.

W.R. Berkley Corp reported no remaining Organogenesis Holdings position as of Q4 2018 after selling out during the quarter.
W.R. Berkley Corp sold 1,108,178 Organogenesis Holdings shares in Q4 2018, an estimated $11.2M.
W.R. Berkley Corp first reported a position in Organogenesis Holdings in Q1 2017 and held it in 7 quarters.
W.R. Berkley Corp's Organogenesis Holdings position peaked at $11.2M in Q3 2018.
0 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q4 2018.

Based on W.R. Berkley Corp's 13F filing for Q4 2018, filed 14 Feb 2019.